セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/11/22 | 1,140 | 1,145 | 1,110 | 1,117 | -29 | -2.5% | 68,100 |
| 2024/11/21 | 1,143 | 1,160 | 1,142 | 1,146 | ±0 | ±0% | 43,800 |
| 2024/11/20 | 1,140 | 1,163 | 1,139 | 1,146 | +19 | +1.7% | 73,300 |
| 2024/11/19 | 1,105 | 1,147 | 1,105 | 1,127 | +20 | +1.8% | 59,900 |
| 2024/11/18 | 1,124 | 1,128 | 1,107 | 1,107 | -24 | -2.1% | 57,900 |
| 2024/11/15 | 1,140 | 1,150 | 1,130 | 1,131 | ±0 | ±0% | 39,200 |
| 2024/11/14 | 1,145 | 1,155 | 1,125 | 1,131 | -10 | -0.9% | 47,700 |
| 2024/11/13 | 1,162 | 1,173 | 1,141 | 1,141 | -21 | -1.8% | 48,300 |
| 2024/11/12 | 1,164 | 1,188 | 1,160 | 1,162 | -2 | -0.2% | 36,500 |
| 2024/11/11 | 1,163 | 1,178 | 1,150 | 1,164 | -10 | -0.9% | 48,100 |
| 2024/11/08 | 1,165 | 1,192 | 1,165 | 1,174 | +5 | +0.4% | 40,600 |
| 2024/11/07 | 1,190 | 1,233 | 1,165 | 1,169 | -22 | -1.8% | 106,700 |
| 2024/11/06 | 1,191 | 1,200 | 1,165 | 1,191 | +14 | +1.2% | 65,400 |
| 2024/11/05 | 1,189 | 1,199 | 1,164 | 1,177 | -11 | -0.9% | 52,100 |
| 2024/11/01 | 1,175 | 1,195 | 1,171 | 1,188 | +1 | +0.1% | 44,600 |
| 2024/10/31 | 1,176 | 1,198 | 1,172 | 1,187 | +5 | +0.4% | 42,600 |
| 2024/10/30 | 1,185 | 1,198 | 1,172 | 1,182 | -6 | -0.5% | 68,800 |
| 2024/10/29 | 1,174 | 1,192 | 1,173 | 1,188 | +14 | +1.2% | 40,000 |
| 2024/10/28 | 1,140 | 1,192 | 1,140 | 1,174 | +34 | +3% | 57,100 |
| 2024/10/25 | 1,194 | 1,194 | 1,136 | 1,140 | -55 | -4.6% | 117,200 |
| 2024/10/24 | 1,205 | 1,205 | 1,180 | 1,195 | -15 | -1.2% | 101,200 |
| 2024/10/23 | 1,252 | 1,252 | 1,204 | 1,210 | -17 | -1.4% | 53,000 |
| 2024/10/22 | 1,252 | 1,264 | 1,221 | 1,227 | -34 | -2.7% | 49,500 |
| 2024/10/21 | 1,300 | 1,300 | 1,259 | 1,261 | +7 | +0.6% | 79,400 |
| 2024/10/18 | 1,199 | 1,269 | 1,181 | 1,254 | +81 | +6.9% | 164,800 |
| 2024/10/17 | 1,209 | 1,227 | 1,170 | 1,173 | -23 | -1.9% | 154,100 |
| 2024/10/16 | 1,212 | 1,228 | 1,195 | 1,196 | -31 | -2.5% | 83,700 |
| 2024/10/15 | 1,220 | 1,260 | 1,216 | 1,227 | +20 | +1.7% | 45,300 |
| 2024/10/11 | 1,255 | 1,255 | 1,207 | 1,207 | -25 | -2% | 67,200 |
| 2024/10/10 | 1,250 | 1,250 | 1,223 | 1,232 | -20 | -1.6% | 44,600 |
| 2024/10/09 | 1,286 | 1,286 | 1,238 | 1,252 | -10 | -0.8% | 53,700 |
| 2024/10/08 | 1,308 | 1,308 | 1,262 | 1,262 | -43 | -3.3% | 43,100 |
| 2024/10/07 | 1,333 | 1,333 | 1,301 | 1,305 | +2 | +0.2% | 51,400 |
| 2024/10/04 | 1,318 | 1,342 | 1,291 | 1,303 | +2 | +0.2% | 54,500 |
| 2024/10/03 | 1,332 | 1,335 | 1,301 | 1,301 | +20 | +1.6% | 43,000 |
| 2024/10/02 | 1,302 | 1,302 | 1,278 | 1,281 | -26 | -2% | 27,400 |
| 2024/10/01 | 1,267 | 1,314 | 1,266 | 1,307 | +57 | +4.6% | 39,600 |
| 2024/09/30 | 1,258 | 1,289 | 1,250 | 1,250 | -55 | -4.2% | 62,800 |
| 2024/09/27 | 1,315 | 1,334 | 1,296 | 1,305 | -3 | -0.2% | 48,900 |
| 2024/09/26 | 1,273 | 1,308 | 1,264 | 1,308 | +36 | +2.8% | 54,300 |
| 2024/09/25 | 1,262 | 1,277 | 1,257 | 1,272 | -2 | -0.2% | 23,700 |
| 2024/09/24 | 1,299 | 1,299 | 1,257 | 1,274 | -15 | -1.2% | 50,100 |
| 2024/09/20 | 1,331 | 1,332 | 1,286 | 1,289 | -43 | -3.2% | 56,400 |
| 2024/09/19 | 1,272 | 1,333 | 1,271 | 1,332 | +77 | +6.1% | 86,400 |
| 2024/09/18 | 1,264 | 1,272 | 1,235 | 1,255 | +18 | +1.5% | 80,300 |
| 2024/09/17 | 1,352 | 1,352 | 1,221 | 1,237 | -117 | -8.6% | 200,000 |
| 2024/09/13 | 1,291 | 1,367 | 1,272 | 1,354 | -27 | -2% | 278,600 |
| 2024/09/12 | 1,384 | 1,425 | 1,380 | 1,381 | +10 | +0.7% | 62,500 |
| 2024/09/11 | 1,393 | 1,419 | 1,355 | 1,371 | -26 | -1.9% | 64,300 |
| 2024/09/10 | 1,418 | 1,437 | 1,393 | 1,397 | -20 | -1.4% | 52,000 |
1～
50
件表示中 / 1240件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| 扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム
